Evidence is emerging that disturbances in sleep and sleep disorders play a role in the morbidity of chronic conditions. However, the relationship between sleep processes, disease development, disease progression and disease management is often unclear or understudied.
INTRODUCTION
Sleep is a natural process and yet the exact purpose of sleep and its effect on health and disease remains to be fully elucidated. Both physiological and pathological sleep is divided into two states: non-rapid-eye-movement (NREM) sleep and rapid-eye movement (REM) sleep []. It has been suggested that it is crucial for the maintenance and restoration of homeostasis through the regulation of energy, repair and infection control and that it may be important in the programming of the brain [l-3] . It is now particularly relevant to understand the importance of sleep, as sleeping habits within our society have been changing over a period of years as a result ofdecreased dependency on day light hours, increased shift-work and changes in lifestyle and home environments [4, 5] . Statistics from the National Sleep Foundation in America suggest that approximately one-third of Americans sleep 6.5 h a night or less Fig. (l) t5l.
It is well established that sleep disorders such as sleep apnoea can lead to serious health problems including cardiovascular disease [6] [7] [8] [9] . New data suggests that 'healthy' individuals who do not get enough sleep might be at risk of poor health in the future [0, 1l] . Moreover, there is increasing evidence to suggest that sleep disturbances may be an impor-*Address correspondence to this author at the Clinical Sciences Research Institute, Clinical Sciences Building-UHCW Campus, Warwick Medical School, Clifford Bridge Road, Coventry, Cyz 2DX, UK; Tel: 024 7696 8666; Fax: 024 7696 8660; E-mail: Michelle.Miller@warwick.ac.uk Fig. (1) . Duration of sleep in the average US population in the last century tant determinant of disease and morbidity and that inflammatory processes may play an important role [2, 3, 12, l3] . A decrease in sleep leads to an increase in inflammatory cytokines which are now believed to be important in the development ofcardiovascular risk progression [2] . Indeed, there is an increased risk of heart attacks and strokes during the early morning and it is possible that sleep has an effect on the endothelial function of blood vessels [14] . This review focuses on risk factors for diabetes and cardiovascular disease and their relationship to sleep and inflammation.
Cardiovascular Disease, Sleep and Inflammation
Individuals who experience sleep problems have been shown to be at an increased risk ofcardiovascular events [9] , which is reduced following successful treatrnent with Con_ tinuous. Positive,Airway pressure (CpAp), surgery (uvulo_ palatopharyngoplasty (Uppp)) or oral applian.r'fr j]. Within the. general population sleep complajnii are ur.y ,o*ron and are often associated with midical, psychologicat and socia-l disturbances [16] . Inflammatory pror.rr., aie impor_ tant in the development and progresiion of cardiovascular disease^and_it is possible that disiurbances in sleep pa$erns may affect these processes Fig. (2) .
insomnia as well as loud snoring, difficulties maintaining s1eep, fatigue, mood effects and impairment of daily activi ties. These factors can lead to an increase in depression, memory problems, a decline in cognitive functioning and a lower quality of life [18, t9,Z0l. The_.ageing process is associated with changes in the metabolic process and disease development and &idence is accumulating to suggest that sleep_deprivation is associated with similarchanges. Furthermore, there is an increasin! body of evidence to suggest that the ageing process, sleei and the inflammatory processes are relaied yZ.i_Z+1.It is im'_ po.r?nt tlat n9! only are sleep regulatory mechanisms stud_ ied but the effect of ageing on ihese processes are determined. A better understanding of the 'boundaries between normal and abnormal age-related changes in sleep behaviour should allow the development of iniervention guidelines. Moreover, the exact nature_ of relationships anj causality between sleep, age and inflammation remain to be eluci_ dated. Increased levels of a number of inflammatory markers in elderly population have been observed, for example CRp and interleukin -6 (IL-6) increase with age [Zt, iZ] . fur_ thermore, partial short term sleep deprivatiin gives rise to a similar pattem of CRp response [23] . Sleep ieprivation is also associated with an increased-gene expiessibn of heat_ shock protein [24l.It is therefore poisible that sleep deprivation may contribute to the increise systemic inflammation observed in ageing. The exact process however remains to be determined but may also involve oxidative stress [25] or the regufation of growth hormone 126l and its associited effect on the immune function.
Gender, Sleep and Inflammation
Men are at increased risk of CVD but it is not clear whether this is associated with gender differences in pattems of sleep. It has also been suggested that the menopause also may be a risk for sleep_disordered breathing (SbB) t271. Gender differences in inflammatory markers have been ob_ served [28] . We have shown that certain adhesion molecule levels are lower in women than in men [2g]. Furthermore, it is possible that the association between iteep anO cardiovas_ cular risk factors such as the Body-Mass_Index (BMI) may vary beh.veen sexes, at least in adolescents. Knutson demon_ strated that while short sleep may have an effect on BMI in young men this does not appear to be the case in young women. [29] .
Ethnicity, Sleep and Inflammation
South Asians have a higher risk of CVD than whites and individuals of African origin appear to be protected from coronary heart disease (CHD) t301.
An increased prevalence of insomnia has been reported in
,Africal
Americanscomp_qgd with whites, which may in part be attributable to ethnic differences in associated risk faclors, :ulh-_3s olgsity l3ll. Ir is not known whether this is preseni in UK African individuals who have a much lower risk of CHD than their American counterpaxts [30] . It has been sug_ gested that there may be a genetic component for this increase [32] and it would therefore be important to study both UK Africans and Africans in Africa. Diibetes and stroke are high in UK Africans as well as African Americans. Ethnic Patients with obstructive sleep apnea (OSA) syndrome who have associated cardiovasculai disease have significantly elevated C-reactive protein (CRp) compared to ihose yjth OSA syndrome but without cardiovascular disease (CVD) or those wirhout OSA syndrome or CVD [12] .
Age, Sleep and Inflammation
Age is a risk factor for cardiovascular disease and ageing and is associated with changes in length and quality ofiteei as well as an increase in the prevalence of sleep complainti [I3]..S.leep problems increas-e with age and the deviloped world.is experiencing an increase in its ageing population. I .ikewise, the number of indiv iduals wittr ctrronic 'illnesses is increasing. It is therefore important that the bidirectional effect of sleep on disease progression and development is evaluated. Fufihermore, it has been demonstrated in young adults that sleep deprivation leads to metabolic, systemic and immune changes that are similar to those observed in ageing and age-related disorders [13] . However, although treitfri elderly adults spend more time in bed, they spend less time asleep and are more easily aroused from sieep than younger individuals [17] . Ageing is associated with an increase in Sleep-Disordered Breathing (SDB), daytime sleepiness and differences in inflammatory markers have been observed [28] which in part are associated with ethnic differences in cardiovascular risk. It is important that future studies investigate whether ethnic differences in CHD, diabetes and stroke are in any way related to differences in sleep disorders and whether or not there may be an underlying inflammatory component.
Obesity, Sleep and Inflammation
Obesity is associated with an increase in SDB and OSA (SAS) [33] . Obesity is becoming a global epidemic in both adults and children and is associated with an increased risk of morbidity and mortality as well as reduced life expectancy [341. It is clear that obesity may have its effect on CVD through a number of different known and possibly as yet unknown mechanisms. These include dyslipidemia, hypertension, glucose intolerance, inflammation, OSAftrypoventilation, and the prothrombotic state [34] . Obesity leads to a change in an individual's metabolic profile and an accumulation of adipose tissue. nisms. Spiegel et al, in the first randomized cross-over clinical trial of short-term sleep deprivation, demonstrated that sleep deprivation was associated with decreased leptin and increased ghrelin levels [35] . This in turn would lead to a cocomittant increase in hunger and appetite, increased insulin resistance and accumulation of fat and decreased carbohydrate metabolism Fig. (3) . The individuals in this study were subjected to extreme acute sleep deprivation (<4 h per night) and further studies are required to determine the effects on these hormones of more modest sleep deprivation (<5 h per night), especially in the long-term [35] . A study of422 children (boys and girls ofprimary school age (5-l0years)) has demonstrated an association between sleep duration and the risk to develop childhood overweight/ obesity [36] . Interestingly, the Nurses Health Study demonstrated that while short sleep duration leads to an increase in weight with time there was no evidence to suggest that this was the result of an increase in appetite [37] . These findings are in contrast to others that have demonstrated a clear relationship between duration of sleep, ghrelin, leptin and appetite [35, 38] . The findings from the Nurses Health Study suggest that perhaps the effects of sleep on obesity occur as a result of a change in energy metabolism. Uncoupling proteins are proteins that L&SK OT SLESF nmut$rr 4rreutr* rs$tst*ltrs dffeste Bnsrgy sfl endih.re 48{platFs aldocrine fLs'*ctio{t ,xri$ nl*ta,]sli$rfl Fig,(3) . Effect ofthe lack ofsleep on energy regulating hormones uncouple proton exchange ald ATp production. polymor_ phjc,variation in these.genes has been ielated to energy me_ tabo,llsm, obesity and diabetes [39, 40] . Furthermore, -irelli et al demonstrated that in animal studies, sleep depiivation was associated with an increase in Uncoupling protein 2 (UCP2) expression in liver and skeletal .ir"iE t4tl. Th; latter is _the largest tissue in the body, -O t rn". and in_ .:T?":d UCP2 expression in this tissue may have a poren_ uauy targe ettect on resting energy expenditure [41] .
.
Inflammatory process may also underlie the elfect of sleep on w_eight gain. Recent itudies have shown the importance ofadipose tissue as an endocrine organ which is capable of.secreting, €unong others, inflammato'ry cytokines [42] . It is.therefore possible that a lack of sleep acting via the regulatory hormones above may lead to un ln..eased fut accumulation and increased secretion of pro_inflammatory cytokines. There is evidence to suggeit that inflammatorv processes .may -!e important in obesity and may mediati some of the effects observed with intreaseO wiigtrt. We demonstrated that an approximate 2yo increase in soluble Eselecrln tevet ls associated with a I unit higher BMI and a 0.01 unit greater Waist-hip_ rario (WHR) J+51. eaiponectln, which is a protective cytokine however,'is not reduced in qlt:nll with OSA compared with matched controls without OSA [44] . In a separate study, individuals with OSA who underwent CPAP treatment had associated changes in in_ flammatory markers (IL-6 and ICAM-l) t451. ih; tevels of Miller and Cappuccio the inflammatory markers were also associated with resistin levels. Likewise, CpAp treatment decreased the levels of ICAM-I and IL-8 [46] . prospective, longirudinal srudies nowever, are required to examine the causal link between sleep and obesity and inflammato.y meaiato.s.
--Glucose and Insulin Regulation, Diabetes, Sleep and In_ flammation.
Diabetes can lead to the development of sleep abnormali_ ties. Findings from the Sleep Heart Health Stuiy indicated that diabetes is associated wiih periodic Ur.utfrin!, a respira_ tory abnormality associated with changes in the ientral con_ T].:t"y^:ltllllon 1a7..)...rr is thousht fliut otuu.t , may bring about sleep abnormalities as a result of its deleterious effecti on central control of breathing. However, it is also important to note. that sleep loss is associated with a decrease in glucose tolerance, a higher evening cortisol level and increied sympathetic activity Fig. ( ). ireatment for OSA has also Deen assocrated with beneficial changes in insulin sensitivity [45] . Further studies are required to iivestigaG whetirer sleep loss can predict changes in glucose rnrtuUoirrn fr-ui.e u.rru.
. Laboratory studies of healthy young adults, demonstrated that recurrent partial sleep re#iction-wa, ^r*iut.d ,ith alterations in glucose metabolism including decreaseO glu_ cose tolerance and insulin sensitivity [4d]. Furtherm6re, sleep restriction led to changes in appeiite'control, in that the levels of the anorexigenic hormone leptin were decreased, whereas the levels of the orexigenic factor ghrelin were increased (see previous Figure ( effect ofsleep on energy regulating hormones)). These changes were associated with an increase in hunger and appetite. Over a long period this may lead to weight gain, insulin resistance and Type 2 Diabetes [48] . A recent longitudinal analysis from the MONICA study has demonstrated that in both women and men the difficulty in maintaining sleep as opposed to the difficulty in initiating sleep was associated with a higher risk of type 2 Diabetes during the subsequent mean follow-up period of 7.5 years ll0l.
These and similar findings have led to the suggestion that sleep and sleep disorders may have a prominent role on metabolic and endocrine functions [49, 50] . There is a large body of evidence to suggest that oxidative stress and inflammation play a large role in the development of diabetes and the development and progression ofthe associated complications [51] . The exact causal pathways remain to be elucidated and likewise it remains to be seen if the diabetic complications associated with sleep disturbances have an underlying inflammatory component.
Blood Pressure, Sleep and Inflammation
Blood pressure normally displays a nocturnal dip of about l0% [52] . Non-dippers are at an inueased risk of CVD and African Americans tend to display more non-dipping characteristics compared to Caucasians and this is associated with an increase in sleep disordered breathing [53] . SDB has been identified as a risk factor for adverse cardiovascular outcomes in the elderly and is also associated with an increase in post stroke mortality [54] . Likewise evidence suggests that OSA palients have an increased incidence of hypertension compared with individuals without OSA, and that OSA is a risk factor for the development of hypertension [7] . Acute deprivation of sleep in healthy subjects leads to an increase in blood pressure and SNS activation and evidence is growing, which suggests that there is a causal relationship between OSA syndrome and hypertension. [8] . A recent longitudinal study demonstrated that short sleep duration (<5 h per night) was associated with a significantly increased risk of hypertension (hazud ratio, 2.10; 95yo CI, 1.58 to 2.79) in subjects between the ages of 32 and 59 years. Furthermore, adjustment for confounding factors such as obesity and diabetes only partially attenuated this relationship [11] . Studies demonstrated an association between hypertension and inflammation but potential causal pathways remain to be examined in more detail. It is however of interest to note that patients with OSA exhibit increased resting heart rate, decreased time duration betr.veen fivo consecutive R waves of the electrocardiogram (R-R interval) variability, and increased blood pressure variability. As well as observed changes in inflammatory mediators such as CRP. OSA is also associated with changes in fibrinogen and plasminogen activator inhibitor [7] , which are important in the development of hypertension and cardiovascular disease.
Lipids, Sleep and Inflammation
OSA may lead to hypoxia and the subsequent generation of reactive oxygen species (ROS). These in tum can lead to Currmt Vascular Pharmacologlt, 20M, VoL S, No. 2 5 an increase in lipid peroxidation. Indeed, increased inflammatory markers and markers of oxidative stress have been found in patients with OSA [55] . Although a recent study concluded that systemic inflammation is a characteristic of OSA patients it failed to find any difference in lipid peroxidation or antioxidant defence (as measured by superoxide dismutase (SOD) between parients with OSA (n=25) and controls (n=17) [55] .
Metabolic Syndrome, Sleep and Inflammation
Metabolic syndrome is characterised by the clustering of cardiovascular and metabolic risk factors in a given individual. These include the presence ofcentral obesity, an adverse lipid profile (high triacyglycerols and low high density lipoprotein (HDL) -cholesterol), raised blood pressure and insulin resistance or glucose intolerance. It has also been suggested that there may be an increased pro-inflammatory state [56] . Furthermore, Vgontzas et al. [57] clearly demonstrated that inflammatory cytokines are increased in individuals with OSA and they proposed that these cytokines were the mediators of excessive daytime sleepiness (EDS). They demonstrated the importance of visceral fat in OSA syndrome. They suggested that sleep apnea and sleepiness in obese patients may be manifestations of the metabolic syndrome. Indeed in the US, data from the Third National Health and Nutrition Examination Survey (1988) (1989) (1990) (1991) (1992) (1993) (1994) has shown that in the US population the prevalence of the metabolic syndrome parallels the prevalence of symptomatic sleep apnoea in general random samples [57] .
Inflammation and Sleep
Immune molecules alter sleep architecture and sleep deprivation alters neuroendocrine and immune response [58] . Furthermore, immune system activation and neuroendocrine responses alter sleep [58] . In addition, sleep quality may affect susceptibility to infection, as well as ones ability to frght off infection [59] . The concentration of high-sensitivity CRP (hsCRP) is predictive of future cardiovascular morbidity [60] and at the same time short sleep duration and sleep complaints are associated with increased cardiovascular morbidity [9, 23] . CRP levels are elevated following both acute total and short term partial sleep deprivation [23] . Compared with control subjects the levels of TNF-c, IL-6, hsCRP, adhesion molecules, and monocyte chemoattractant protein-l are markedly and significantly elevated in patients with sleep apnoea [61]. Short term sleep deprivation gives rise to a number of effects on the immune system including a decrease in cellular immune response on the following day 12,62]. Likewise, the immune response to viral challenge is also reduced [63] . It remains to be elucidated whether similar effects on the immune system are observed in individuals with long-term sleep deprivation.
As well as infectious agents, it is known that other diseases can lead to an increase in systemic inflammation such as arthritis. Studies in patients with rheumatoid arthritis have revealed pattems of sleep disturbances that arc not associated with the concomitant pain [64] . The innate immune system pathway can be activated by the outer lipopolysaccharide (LPS) component of bacterial cell membranes [65] . Such stimulation of the innate immune system occurs through toll-like receptors and can lead to an increase in inflammatory cytokines Fig. (5) . [66] . In.rats, a 30 day infusion of LpS led ti a loss of nypocretln neurons. This suggests that LpS and the resulting inflamm.ation may play a rolJ in the loss of hypocretin neurons which occur in sleep disorders such as narcolepsy [62] .^I n human studies, Gundersen et al. [6g) investigated the effect of prolonged physical activity with'concomitant en_ ergy and_ sleep deprivation on leukocyte function. They demonstrated. that leukocytes responded with an increasing re_ Iease of inflammatory cytokines when challenged with LpS as the study-progressed. Furthermore, they fiund that the response to the anti-inflammatory agent hydrocortisone was reduced. These results demonstrate that multifactoral stress can activate immune cells and prime their response to a microbial challenge [63] . However, it is important to note that sleep deprivation can alter catecholamaines [69] , which in turn may have an effect on white blood cells. The'exact part played and the importance of the sleep deprivation in rhis multifactorial stress needs to be further inu.rtigut.d.
LPS increases NREM and reduce REM sleep in rabbits
The intermittent hypoxia/reoxygenation process that oc_ curs in OSA syndrome is associated with a ielective activa_ Miller and Cappuccio tion of .inflamm-at9ry processes as demonstrated by the increase in . circulating tumour necrosis factor_alph; (TNF_ {pha) .and NFkappaB levels whereas adaptive pathways as d_etermined by the measurement of the aOaptiie regulator HIF-l are not increased [70] . Fr:rthermore, CirAp theiapy is able to normalise the incieased TNF_alpha t.uet, JZOI. ilsa syndrome is associated with an increased monocyte NF-Iuppug activity. Moreover this is also associated with an increased expression of iNOS protein [71] . Further information on the links beh.veen the innate immune system and sleep can be found in a recent review [3] . as present in sleep apnoea, narcolepsy, and idiopathic nypersomnla are associated with an increase in the secretion *lrea* h*rmsnsn Frc**smr?usarii* Ertsldns*; **r#.ffia rxrn*t*ry caspNrlne,#: ffi$ergy' regu*nllefx AFpgfftu Efifitr#* Fig' (5) . Possible interaction between the innate immune system and sleep regulation Inflammation, Sleep, Obesig and Cardiovascular Disease of inflammatory markers [73] . It has also been suggested that HPA axis hyperactivity may be a consequence of OSA and may indeed contribute to secondary pathologies such as hypertension and insulin resistance. [72] . On awakening, there is a rise in cortisol levels. The time of awakening and stress are thought to influence the magnitude of the cortisol awakening response (CAR) 1741. A recent study which examined men and women London Underground shift-workers suggested that early-waking, stress early in the day, and associated cortisol levels often coincide with sleep disturbance. [74] . In a recent pilot study, which examined the sleep and the stress-induced cortisol response in children and adolescents, there were signifrcant associations between the selfreported sleep quality but not quantity and the cortisol response [75] .
Depression, Sleep and Inflammation
When compared with controls depressed patients have a significant nocturnal increase in circulating IL-6 and sICAM [76] . Furthermore both sleep latency and REM density are associated with these inflammatory markers [76] . It is of interest to note that in patients with depression, total sleep deprivation leads to an increase in renin secretion and a concomitant trend for a decrease in HPA axis activity in the recovery night [77] . lt has been suggested that these changes could be a "fingerprint" of a rapidly antidepressive treatment 1771.
Social Economic Status (SES), Sleep and Inflammation
Low SES is frequently associated with sleep deprivation and ethnic differences in SES and sleep patterns exist [78] . African American children have an increase in sleep disordered breathing compared with white Caucasians which could contribute to an increase in inflammatory processes and associated CVD risk [79] . However, further studies are required to examine this hypothesis.
Alcohol, Sleep and Inflammation
There is some inconsistency in the literature but in general it is accepted that moderate-to-large quantities ofalcohol are capable ofaggravating severe OSA [80] . It has also been suggested that there are inter-relationships between alcoholism, sleep loss and ethnicity, which may also operate in a bidirectional manner [81] . It has been postulared that disturbed sleep patterns effect hormonal, autonomic nervous system and immune function and might contribute to the increased mortality rate observed in African American alcoholics [81] .
Paediatrics, Sleep and Inflammation
Children with sleep disordered breathing have higher CRP levels than children who do not [82] . Furthermore, 947o of the children studied who had elevated CRP levels also reported excessive daytime sleepiness or learning difficulties as compared to 620/o of children who had CRP levels in the normal range [82] .
Genes, Sleep and Inflammation
In the brain the sleep-wake cycle is regulated by the central circadian oscillator in the hypothalamic suprachiasmatic nuclei (SCN) [83] . This oscillator is composed of many Catmt Vasculdr Pharmacolog420M, VoL S, No. 2 7 genes and proteins which interact together and have both positive and negative feedback loops [83] . Among others, the CLOCK and BMALI elements promote the expression of the Period (pefl, 2 and 3) and Crytochrome (Cryl | & 2) genes. It is known that genetic variation in some of these genes, including Period 2, is important in the development of some sleep disorders [84] . Ifit is possible to identift genes and gene products which contribute to sleep disorders it would be interesting to study their associations in children, as well as adults, as the former are less likely to be influenced by age-associated comorbidities, which are present in the adult populations. However, sleep disorders do exist in some children which need to be excluded or diagnosed in such studies.
A recent literature review led to the suggestion that inflammatory cytokines such as TNF-alpha and Interleukin -1(L-1) perform neural functions in normal brains As such they should be regarded as both neuromodulators as well as inflammatory mediators [85] . The genes coding for these cytokines and their accessory proteins are expressed by glial cells and neurones in the normal brain [85] . Receptors for these cytokines are present on neural cells [85] . Patients with OSA syndrome have elevated TNF-alpha levels [86] . The -308,4. TNF-alpha gene polymorphism is responsible for increased TNF-alpha production. Individuals with OSA syndrome and their siblings are more likely to carry this polymorphism than population controls; once more indicating that an increase in inflammatory mediators may be important in the pathogenesis of OSA syndrome [87] .
Genetic and environmental factors may act together to influence the set-point at which a given individual's neroendocrine stress responses and cytokine production pattems respond to different pathogens or antigens [S8]. It is therefore possible that genetic determinants of sleep acting on the oxidative and immune pathways may also be of importance in determining an individual's subsequent cardiovascular risk.
Sleep and Pharmacological Treatments
OSA is characterized by a collapse of the airway that occurs during sleep [89] . As a result there is a lack ofoxygen to the brain and the individual wakes up so that breathing is resumed [89] . This can be repeated several times in one night and results in fragmented sleep. One of the most common treatrnents for this condition is CPAP [89] . This maintains the airway during sleep. However, in some individuals the daytime sleepiness associated with OSA and other sleep disorders is not always eliminated by this treatment. Although the exact mechanisms that govern the sleep-wake cycle and the process are unknown. It is of interest to note that a relatively new drug, Modafinil is effective against excessive daytime sleepiness [90]. It would appear that this drug exerts some of its action in the hypothalamus, which is an area of the brain that regulates sleep-wake functioning [90] . 5-hydroxytryptophan (5-HT) increases serotonin levels and is used to treat depression [91] . There has been some suggestion that it may improve sleep patterns and aid weight loss. A recent study, which investigated the effect of sleep deprivation on 5-HT tumover, indicated that REM sleep modulated the 5-HT tumover in the brain in a region_specific manner [92] .
Given the suggestion that poor sleep may have cardiovascular consequences as a result of its effect on the inflam_ m?tor7 ard oxidative pathway, it is possible that the pharmacological management of sleep disorders may need to in_ clude anti-inflammatory and antioxidant agentjas well.
The Importance of Sleep _ 91..p is a fundamental requirement for living individuals. In this review we discussed how changes in sleep, acting through inflammatory mechanisms, may be associated with an increased risk of CVD. Changes in working pattems and increased demands on individual's time ,"quire that more individuals are awake for longer periods oltime. Unfortu_ nately, increases in shift work, on-call rotas and prolonged working hours result not only in a potentially increased cardiovascular risk but also an increased risk of fatigue and ac_ cidents e.g. road traffic accidents, commuter tra]n disasters and pilot error as well as medical enors [93,94J. Driving while drowsy has a similar effect to driving-undeithe influl ence of alcohol. It is believed that substantial numbers of medical errors result from fatigue due to adverse sleep pat_ terns in nurses and doctors [4] . These problems trave a ]iigtr cost both in terms of human life and economic factois. Hence, it can be seen that sleep has a major impact on our health and well-being and needs to be researched ihoroughly. Some of these problems associated with the lack of Jleen cou.ld be_addressed by improving our understanding of the biological basis of sleep; the biochemical mechaniims; inv.olve.d, byincreasing awaxeness both among health professionals and among the lay public, and by making changes to work patterns and access to sleep recovery (naps/ timi offl as well as improved diagnosis and treatment resimes.
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